Comparison of temozolomide-capecitabine to 5-fluorouracile-dacarbazine in 247 patients with advanced digestive neuroendocrine tumors using propensity score analyses
de Mestier, Louis, Walter, Thomas, Brixi, Hedia, Evrard, Camille, Legoux, Jean-Louis, de Boissieu, Paul, Hentic, Olivia, Cros, Jérôme, Hammel, Pascal, Tougeron, David, Lombard-Bohas, Catherine, RebourLanguage:
english
Journal:
Neuroendocrinology
DOI:
10.1159/000498887
Date:
February, 2019
File:
PDF, 662 KB
english, 2019